SCHEMBL7593155

SCHEMBL7593155

CN(CCNc1nc2c([N+](=O)[O-])cccc2n1C(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.38
NR1H2 P55055 11/20 0.35
DCTPP1 Q9H773 2/20 0.34
AURKA O14965 1/20 0.34
RPS6KB1 P23443 1/20 0.34
ADORA3 P0DMS8 2/20 0.32
LMNA P02545 1/20 0.32
NR1H3 Q13133 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32
DRD2 P14416 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
CHRM3 P20309 1/20 0.32
MAOA P21397 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADORA2A P29274 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7475885 0.92 CHRM2 (0.37) NR1H2DCTPP1ADORA3LMNACHRM2
SCHEMBL7481535 0.85 AAK1 (0.41) AAK1NR1H2NR1H3
SCHEMBL7965370 0.83 BRD4 (0.44) NR1H2ADORA3ADORA2A
SCHEMBL7459831 0.77 AAK1 (0.38) AAK1NR1H2NR1H3CHRM2CHRM1
SCHEMBL7484398 0.76 CKS1B (0.42) NR1H2DCTPP1
SCHEMBL7595112 0.76 NR1H2 (0.41) NR1H2NR1H3
SCHEMBL7484481 0.76 DCTPP1 (0.47) NR1H2DCTPP1LMNANR1H3
SCHEMBL7484393 0.71 NR1H2 (0.34) NR1H2DCTPP1ADORA3NR1H3
SCHEMBL7647352 0.69 ALDH1A1 (0.48)
SCHEMBL30408067 0.69 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
EP-0946519-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 EP disclosed
WO-1998024771-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-11 WO disclosed